Cart
sales@molnova.com
BPH-1358
CAS No. 5352-53-4
BPH-1358( NSC50460 )
Catalog No. M24517 CAS No. 5352-53-4
BPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 141 | In Stock |
|
| 10MG | 226 | In Stock |
|
| 25MG | 377 | In Stock |
|
| 50MG | 527 | In Stock |
|
| 100MG | 709 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBPH-1358
-
NoteResearch use only, not for human use.
-
Brief DescriptionBPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor.
-
DescriptionBPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor. With IC50s of 1.8 μM and 110 nM, respectively. And it is active against S. aureus in vitro (MIC ~250 ng/mL).
-
In VitroBPH-1358 is the most potent inhibitor of both E. coli UPPS (EcUPPS) as well as S. aureus UPPS (SaUPPS) with an IC50 of 110 nM. BPH-1358 against E. coli and S. aureus with EC50 of 300 nM and 290 nM, respectively.
-
In VivoBPH-1358 is active against S. aureus in vivo (20/20 mice survived in an i.p. infection model with a MRSA strain).
-
SynonymsNSC50460
-
PathwayOthers
-
TargetOther Targets
-
Recptorhuman bisphosphonate farnesyl diphosphate synthase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5352-53-4
-
Formula Weight601.53
-
Molecular FormulaC32H30Cl2N6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 6.25 mg/mL (10.39 mM)
-
SMILESO=C(C1=CC=C(C2=CC=C(C(NC3=CC=CC(C4=NCCN4)=C3)=O)C=C2)C=C1)NC5=CC=CC(C6=NCCN6)=C5.[H]Cl.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Etifoxine hydrochlor...
Etifoxine is an anxiolytic and anticonvulsant drug.?Unlike benzodiazepines, etifoxine appears to produce its anxiolytic effects by binding to β2 and β3 subunits of the GABAA receptor complex, and so is acting at a different target site to benzodiazepines, although the physiological effect that is produced is similar to that of benzodiazepines.
-
Cajanin
Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.
-
3-Benzoylpyridine
3-Benzoylpyridine is a decomposition product of HGG-12 which is the soman antidote.
